GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ingevity Corp (NYSE:NGVT) » Definitions » Total Current Liabilities

Ingevity (Ingevity) Total Current Liabilities

: $363 Mil (As of Dec. 2023)
View and export this data going back to 2016. Start your Free Trial

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Ingevity's total current liabilities for the quarter that ended in Dec. 2023 was $363

Ingevity Total Current Liabilities Historical Data

The historical data trend for Ingevity's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ingevity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Liabilities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.50 223.40 268.90 303.50 362.90

Ingevity Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Current Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 303.50 278.80 311.10 305.10 362.90

Ingevity Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Ingevity's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=244.7+103.1
+Other Current Liabilities+Current Deferred Liabilities
=15.1+0
=363

Ingevity's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=244.7+103.1
+Other Current Liabilities+Current Deferred Liabilities
=15.1+0
=363

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Ingevity Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Ingevity's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ingevity (Ingevity) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ingevity Corp (NYSE:NGVT) » Definitions » Total Current Liabilities
Comparable Companies
CCF HWKN OEC SCL MTX ECVT KRO WTTR KOP MATV LIN XPAR:AI APD SHW ECL SHSE:600309 XSWX:SIKA BOM:500820 DD XSWX:GIVN
Traded in Other Exchanges
IGX:Germany
Address
4920 O'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405
Website
https://www.ingevity.com
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals which find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focusses on automotive carbon products used in automobiles. The Company sells its products worldwide, with special emphasis on North America.
Executives
Christine Stunyo officer: SVP, Chief HR Officer 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
White Richard Allen Jr officer: SVP, Perf Chem and Pres, ISPT 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405
Phillip John Platt officer: VP, CAO & Corporate Controller 5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Woodcock Stuart Edward Jr. officer: EVP, President Perf Materials 5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Bruce D. Hoechner director 2225 W CHANDLER BLVD, CHANDLER AZ 85224
Erik Spencer Ripple officer: Chief Growth & Innov Officer 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
Benjamin G. Wright director 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
William J Slocum director C/O INCLUSIVE CAPITAL PARTNERS, L.P., 1170 GORGAS AVENUE, SAN FRANCISCO CA 94129
J Michael Fitzpatrick director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612-4662
Diane H. Gulyas director C/O EXPEDITORS, 1015 THIRD AVENUE, SEATTLE WA 98104
Jean S Blackwell director
Frederick J Lynch director C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Luis M Fernandez-moreno director ASHLAND INC., 8145 BLAZER DRIVE, WILMINGTON DE 19808
Karen G Narwold director ALBEMARLE CORPORATION, 4250 CONGRESS ST, SUITE 900, CHARLOTTE NC 28209
Steven Paul Hulme officer: SVP, Perf Chem and Pres, EP 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405

Ingevity (Ingevity) Headlines

From GuruFocus

Ingevity enters battery electric vehicle market, invests $60 million in lithium-ion anode materials producer, Nexeon, and secures future activated carbon supply relationship

By Business Wire Business Wire • 08-02-2022

Ingevity announces dates for second-quarter 2023 earnings release and webcast

By Business Wire • 07-19-2023

Ingevity extends partnership with TRiiSO, LLC, expands Capa� distribution footprint for customers in the United States and Canada

By Business Wire • 11-28-2023

Ingevity appoints Christine Stunyo as chief human resources officer

By Business Wire Business Wire • 06-27-2022

Ingevity to acquire leading pavement marking materials business, Ozark Materials

By Business Wire Business Wire • 08-02-2022

Ingevity highlights actions as a catalyst for good in 2022 sustainability report, announces new sustainability goals

By Business Wire Business Wire • 05-18-2023

Ingevity's Capa� thermoplastics recognized for providing biodegradable solutions for agricultural and horticultural applications, awarded OK biodegradable SOIL certification

By Business Wire • 06-23-2023

Ingevity announces changes to its Board of Directors

By Business Wire Business Wire • 07-27-2022

Ingevity publishes environmental product declaration for its Evotherm M1 Warm Mix Asphalt technology

By Business Wire Business Wire • 05-12-2022

Ingevity's North Charleston plant to maintain continued operations with announced closure of WestRock's adjacent North Charleston paper mill

By Business Wire Business Wire • 05-02-2023